Sample preparation

AK Archit Kumar
JW Jiawei Wang
AE Allen Esterly
CR Chris Radcliffe
HZ Haowen Zhou
BW Brent Vander Wyk
HA Heather G. Allore
ST Sui Tsang
LB Lydia Barakat
SM Subhasis Mohanty
HZ Hongyu Zhao
AS Albert C. Shaw
HZ Heidi J. Zapata
ask Ask a question
Favorite

Peripheral blood mononuclear cells (PBMCs) were isolated from heparinized blood using Ficoll gradient centrifugation (Histopaque Sigma) as previously described [18, 64]. Freshly isolated PBMCs were stimulated with 10 μg/ml of whole glucan particles (WGP Dispersable or 1,3/1,6-β-glucan) (InvivoGen, tlr-wgp) which is a specific Dectin-1 agonist that lacks TLR stimulating activity—for 18 hours (for Monocyte experiments), and 12 hours (for dendritic cell experiments) in RPMI medium supplemented with 10% fetal bovine serum and Penicillin/Streptomycin/L-Glutamine at 37° C. WGP (Soluble, or 1,3/1,6-β-glucan) (Invivogen tlr-wgps) was used as a negative control. WGP soluble particles can bind to the Dectin-1 receptor without activating it. Baseline samples were completely unstimulated. Brefeldin-A (GolgiPlug, BD Biosciences) was added for the last 6 hours of stimulation. Cells were then surface stained with anti-CD14-PE-CF594 (3G8, BD-Biosciences), anti-CD16-PE-Cy7 (3G8, BD-Biosciences), and anti-CD11b-APC-Cy7 (ICRF44, BD-Biosciences) to identify monocytes and separate them into activate, inflammatory, classical and non-classical subsets. Dendritic cells were identified by staining for lineage markers (CD3, CD14, CD16, CD19, PE-TXR, BD Biosciences) in a general dump gate. Lineage negative cells that were also anti-HLA DR+-APC-Cy7) (LN3, eBioscience) (Lin-/HLA DR+) were then stained for anti-CD11c-PE-Cy7 (3.9, eBioscience), and anti-CD123-APC (7G3, BD Biosciences) to separate dendritic cells into myeloid dendritic cells (CD11c+, CD123-), and plasmacytoid cells (CD11c-, CD123+). Cells were fixed in Cytofix buffer (BD-Biosciences) and stored at -80° C in freezing medium until analyzed using flow cytometry. On the day of analysis cells were thawed, washed, and permeabilized with Cytofix/Cytoperm (BD-Biosciences) and Perm/Wash buffer (BD-Biosciences) for intracellular cytokine staining with anti-interleukin-10 (IL-10) Pacific Blue (JES3-9d7, eBioscience), anti-interleukin-12 p70 (IL-12) PE (20C2, BD Biosciences), anti-interleukin-6 (IL-6) fluorescein isothiocyanate (MQ2-13A5, eBioscience), and anti-tumor necrosis factor-α (TNF-α) Alexafluor 700 (MAB11, BD Biosciences) for monocyte staining. Dendritic cells intracellular staining used the following antibodies: anti-IFN-α-FITC (pbl interferon source, 21112-3), anti-interleukin-12 p70 (IL-12) PE (20C2, BD -Biosciences), anti-IL-6-Alexaflour 700 (MQ2-13A5, eBioscience), anti-tumor necrosis factor-α (TNF-α)-Pacific blue (Mab11, eBioscience). Samples were run using a Fortessa LSRII flow cytometer (Becton Dickinson) and analyzed using FlowJo software (FlowJo, LLC). A general gating strategy is shown in Supplementary Figure 1. Cells were also analyzed for Dectin-1 surface expression (anti-Dectin-1, 15E2, eBioscience) by flow cytometry.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A